Home News Weather Finance Travel Maps Movies Lottery Horoscopes Games
 SECTION: DISEASE, MEDICINE, HEALTH CARE RESEARCH
Search The Web:
DOMAIN NAMES
AS LOW AS $2.99 / YR.
Interim Guidance For Drugs To Prevent HIV
Friday, 28-Jan-2011 4:34PM United Press International
USTINET NEWS

  Front Page

  Top Stories

  U.S.

  World

  Politics

  Business

  Sports

  Health

  Tech/Science

    Aerospace & NASA

    Computers

    Electronics

    Environment

    Nuclear

    Science

    Telecomm

  Living/Entertainment

  Off Beat Stories

  News Photos

  Weather


Special Editions

  Iraq & Conflict

  Israel/Palestine

  Crimes & Laws


MultiMedia

  Interactive Features

  News Photos


POLL: Your Opinion

  What Do You Think




ATLANTA, Jan. 27 (UPI) -- The Centers for Disease Control and Prevention in Atlanta has issued interim guidance in the use of Pre-Exposure Prophylaxis as an HIV prevention strategy.

SAVE MONEY ON TRAVEL DEALS

In PrEP studies, people who are at high risk of HIV but are HIV negative take anti-retroviral medication daily to try to lower their chances of becoming infected with HIV if they are exposed.

The CDC's Morbidity and Mortality Weekly Report, released Thursday, said the National Institutes of Health announced trial results in November providing the first evidence that daily oral use of an anti-retroviral drug used to treat HIV can also help prevent sexually-acquired HIV among men who have sex with men, when delivered as a part of comprehensive HIV prevention services.

Until detailed guidelines are available, CDC is providing interim guidance.

"The CDC underscores the importance of targeting PrEP to men who have sex with men at high-risk for HIV is a part of comprehensive HIV prevention services, which should include risk-reduction and medication adherence counseling, condoms and testing and treatment for other sexually-transmitted infections", the report said. "The guidance stresses the need to ensure any men who have sex with men who may be prescribed PrEP are confirmed to be HIV negative prior to use, as well as the need for regular monitoring of HIV status, side effects, adherence and risk behavior among those taking PrEP."

- - - - - - - - - - - - - - - - - - - -
Related News Topics:

Sexual issues and news of sexuality
HIV and AIDS research, politics
Top science, technical and computer stories
Disease, medicine, health care research
Social issues
Miscellaneous science and technology stories
Disease, medicine, aids, health care research

 BREAKING STORIES

Why broccoli may prevent cancer

Women given wrong breast cancer results

EU envoy: Political uproar threatens Haiti

Loud traffic noise linked to stroke risk

Cleanliness of girls may up asthma risk

Interim guidance for drugs to prevent HIV

Lura Ryan's condition 'very grave'

Unrealistic optimism may taint trials

Food-borne bacteria can fatally hit heart

Caffeine 'jazzes' engineered cells

Teens should get meningococcal booster

U.N. warns of Asian foot-and-mouth threat

World-wide debate over smallpox virus

Waitress fired for bald cancer support

Diplomat: Hospitalization caused by stress

Diabetics, spouses may feel stress

Exercise improves street-crossing speed

Hair stylists question chemical in relaxer

Hot flashes linked to fewer breast cancers

Rhabdomyolysis cited in Iowa hospitalizations

Home News Weather Finance Travel Maps Movies Lottery Horoscopes Games
Home :: My Page :: My WebMail :: My Calendar :: My Portfolio :: Chat :: Help Center :: Sign In :: Sign Out

MY.USTI.NET PORTAL  -  1996 - 2004 USTINET CORPORATION. ALL RIGHTS RESERVED.
Please see our Privacy Policy, Security Guarantee, Terms of Use for additional information.